NCT05712278 - A Study to Investigate Use of Off-the-shelf Natural Killer (NK) Cells (SAR445419) in Relapsed/Refractory Acute Myeloid Leukemia | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

June 16, 2023

Primary Completion Date

February 23, 2024

Study Completion Date

March 12, 2024

Conditions

Acute Myeloid Leukaemia

Interventions

DRUG

SAR445419

Cell suspension, by intraveneous (IV) injection

DRUG

fludarabine

Solution for injection , by IV injection

DRUG

cytarabine

Solution for injection, by IV injection

Trial Locations (3)

Albert Einstein College of Medicine Site Number : 8400001, The Bronx

~MD Anderson Cancer Center Site Number : 8400002, Houston

University of Nebraska Medical Center Site Number : 8400003, Omaha